FDA NDC Directory · JSON-LD · Markdown

Erythromycin Ethylsuccinate

NDC 62559-630 · HUMAN PRESCRIPTION DRUG · GRANULE, FOR SUSPENSION

Labeler / ManufacturerANI Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA062055
Dosage form / routeGRANULE, FOR SUSPENSION · ORAL
Active ingredientsERYTHROMYCIN ETHYLSUCCINATE (200 mg/5mL)
Marketing started20190325
Package count1

External sources

Source: openFDA. Public-domain (CC0).